Insider · CIK 0001697422

Fenimore Christopher R.

Reports to the SEC for 1 company · TARRYTOWN, NY

sec.gov

Transactions

Companies

Filings

CIK

0001697422

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-18	REGNREGENERON PHARMACEUTICALS, INC. · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	EVP Finance CFO	MExercise/Conversion	−6,283 sh	—	—	6,000
2026-08-18	REGNREGENERON PHARMACEUTICALS, INC.F Tax Payment	EVP Finance CFO	FTax Payment	−4,599 sh	$813.47	−$3.74M	19,984
2026-08-18	REGNREGENERON PHARMACEUTICALS, INC.M Exercise/Conversion	EVP Finance CFO	MExercise/Conversion	+6,283 sh	$381.92	+$2.4M	24,583
2025-12-08	REGNREGENERON PHARMACEUTICALS, INC.F Tax Payment	EVP Finance CFO	FTax Payment	−992 sh	$712.94	−$707K	18,300
2025-12-05	REGNREGENERON PHARMACEUTICALS, INC. · Non-Qualified Stock Option (right to buy)A Award	EVP Finance CFO	AAward	+14.9K sh	—	—	14,924
2025-12-05	REGNREGENERON PHARMACEUTICALS, INC.A Award	EVP Finance CFO	AAward	+3,027 sh	—	—	19,292
2024-12-16	REGNREGENERON PHARMACEUTICALS, INC.F Tax Payment	EVP Finance CFO	FTax Payment	−491 sh	$730.81	−$359K	16,265
2024-12-09	REGNREGENERON PHARMACEUTICALS, INC.F Tax Payment	EVP Finance CFO	FTax Payment	−1,140 sh	$787.00	−$897K	16,756
2024-12-06	REGNREGENERON PHARMACEUTICALS, INC. · Non-Qualified Stock Option (right to buy)A Award	EVP Finance CFO	AAward	+9,979 sh	—	—	9,979
2024-12-06	REGNREGENERON PHARMACEUTICALS, INC.A Award	EVP Finance CFO	AAward	+2,591 sh	—	—	17,896
2024-08-28	REGNREGENERON PHARMACEUTICALS, INC.S Sale	EVP Finance CFO	SSale	−450 sh	$1206.15	−$543K	0
2024-08-28	REGNREGENERON PHARMACEUTICALS, INC.S Sale	EVP Finance CFO	SSale	−200 sh	$1206.70	−$241K	25
2024-08-28	REGNREGENERON PHARMACEUTICALS, INC.S Sale	EVP Finance CFO	SSale	−236 sh	$1205.67	−$285K	225
2024-08-28	REGNREGENERON PHARMACEUTICALS, INC.S Sale	EVP Finance CFO	SSale	−228 sh	$1204.79	−$275K	966
2024-08-28	REGNREGENERON PHARMACEUTICALS, INC.S Sale	EVP Finance CFO	SSale	−200 sh	$1206.30	−$241K	0
2024-08-28	REGNREGENERON PHARMACEUTICALS, INC.S Sale	EVP Finance CFO	SSale	−766 sh	$1205.44	−$923K	200
2024-08-28	REGNREGENERON PHARMACEUTICALS, INC.S Sale	EVP Finance CFO	SSale	−200 sh	$1206.67	−$241K	25
2024-08-28	REGNREGENERON PHARMACEUTICALS, INC.S Sale	EVP Finance CFO	SSale	−2,237 sh	$1204.71	−$2.69M	1,378
2024-08-28	REGNREGENERON PHARMACEUTICALS, INC.S Sale	EVP Finance CFO	SSale	−235 sh	$1205.67	−$283K	225
2024-08-28	REGNREGENERON PHARMACEUTICALS, INC.S Sale	EVP Finance CFO	SSale	−928 sh	$1205.49	−$1.12M	450
2024-02-09	REGNREGENERON PHARMACEUTICALS, INC.S Sale	EVP Finance CFO	SSale	−344 sh	$950.49	−$327K	18,947
2024-02-09	REGNREGENERON PHARMACEUTICALS, INC.S Sale	EVP Finance CFO	SSale	−1,100 sh	$954.57	−$1.05M	14,972
2024-02-09	REGNREGENERON PHARMACEUTICALS, INC.S Sale	EVP Finance CFO	SSale	−1,342 sh	$953.47	−$1.28M	16,072
2024-02-09	REGNREGENERON PHARMACEUTICALS, INC.S Sale	EVP Finance CFO	SSale	−600 sh	$955.00	−$573K	14,372
2024-02-09	REGNREGENERON PHARMACEUTICALS, INC.S Sale	EVP Finance CFO	SSale	−487 sh	$951.39	−$463K	18,460
2024-02-09	REGNREGENERON PHARMACEUTICALS, INC.S Sale	EVP Finance CFO	SSale	−1,046 sh	$952.62	−$996K	17,414
2024-01-23	REGNREGENERON PHARMACEUTICALS, INC.M Exercise/Conversion	EVP Finance CFO	MExercise/Conversion	+5,000 sh	$555.67	+$2.78M	21,860
2024-01-23	REGNREGENERON PHARMACEUTICALS, INC. · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	EVP Finance CFO	MExercise/Conversion	−5,000 sh	—	—	0
2024-01-23	REGNREGENERON PHARMACEUTICALS, INC. · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	EVP Finance CFO	MExercise/Conversion	−5,000 sh	—	—	0
2024-01-23	REGNREGENERON PHARMACEUTICALS, INC.F Tax Payment	EVP Finance CFO	FTax Payment	−3,583 sh	$948.50	−$3.4M	19,291
2024-01-23	REGNREGENERON PHARMACEUTICALS, INC.M Exercise/Conversion	EVP Finance CFO	MExercise/Conversion	+5,000 sh	$399.66	+$2M	22,874
2024-01-23	REGNREGENERON PHARMACEUTICALS, INC.F Tax Payment	EVP Finance CFO	FTax Payment	−3,986 sh	$948.50	−$3.78M	17,874
2024-01-03	REGNREGENERON PHARMACEUTICALS, INC.F Tax Payment	EVP Finance CFO	FTax Payment	−3,469 sh	$912.30	−$3.16M	16,860
2024-01-03	REGNREGENERON PHARMACEUTICALS, INC.M Exercise/Conversion	EVP Finance CFO	MExercise/Conversion	+5,000 sh	$399.66	+$2M	20,329
2024-01-03	REGNREGENERON PHARMACEUTICALS, INC.F Tax Payment	EVP Finance CFO	FTax Payment	−4,043 sh	$912.30	−$3.69M	15,329
2024-01-03	REGNREGENERON PHARMACEUTICALS, INC.M Exercise/Conversion	EVP Finance CFO	MExercise/Conversion	+5,000 sh	$555.67	+$2.78M	19,372
2024-01-03	REGNREGENERON PHARMACEUTICALS, INC. · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	EVP Finance CFO	MExercise/Conversion	−5,000 sh	—	—	5,000
2024-01-03	REGNREGENERON PHARMACEUTICALS, INC. · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	EVP Finance CFO	MExercise/Conversion	−5,000 sh	—	—	5,000
2023-12-27	REGNREGENERON PHARMACEUTICALS, INC.S Sale	EVP Finance CFO	SSale	−2,448 sh	$856.71	−$2.1M	14,372
2023-12-22	REGNREGENERON PHARMACEUTICALS, INC.S Sale	EVP Finance CFO	SSale	−250 sh	$846.27	−$212K	16,820
2023-12-21	REGNREGENERON PHARMACEUTICALS, INC.S Sale	EVP Finance CFO	SSale	−1,224 sh	$844.09	−$1.03M	17,070
2023-12-21	REGNREGENERON PHARMACEUTICALS, INC.S Sale	EVP Finance CFO	SSale	−456 sh	$843.79	−$385K	18,294
2023-12-12	REGNREGENERON PHARMACEUTICALS, INC.F Tax Payment	EVP Finance CFO	FTax Payment	−2,552 sh	$856.71	−$2.19M	18,750
2023-12-11	REGNREGENERON PHARMACEUTICALS, INC.F Tax Payment	EVP Finance CFO	FTax Payment	−1,276 sh	$844.09	−$1.08M	21,562
2023-12-11	REGNREGENERON PHARMACEUTICALS, INC.F Tax Payment	EVP Finance CFO	FTax Payment	−260 sh	$844.09	−$219K	21,302
2023-12-08	REGNREGENERON PHARMACEUTICALS, INC. · Non-Qualified Stock Option (right to buy)A Award	EVP Finance CFO	AAward	+8,499 sh	—	—	8,499
2023-12-08	REGNREGENERON PHARMACEUTICALS, INC.A Award	EVP Finance CFO	AAward	+2,370 sh	—	—	22,838
2023-12-08	REGNREGENERON PHARMACEUTICALS, INC.F Tax Payment	EVP Finance CFO	FTax Payment	−474 sh	$843.79	−$400K	20,468
2023-08-23	REGNREGENERON PHARMACEUTICALS, INC.F Tax Payment	EVP Finance CFO	FTax Payment	−5,198 sh	$842.66	−$4.38M	20,942
2023-08-23	REGNREGENERON PHARMACEUTICALS, INC.M Exercise/Conversion	EVP Finance CFO	MExercise/Conversion	+7,000 sh	$399.66	+$2.8M	26,140

Recent filings

Accepted (ET)
Aug 204
Fenimore Christopher R.0001697422-26-000002
SEC(opens sec.gov)
Dec 94
Fenimore Christopher R.0001697422-25-000004
SEC(opens sec.gov)
Dec 184
Fenimore Christopher R.0001883850-24-000061
SEC(opens sec.gov)
Dec 104
Fenimore Christopher R.0001883850-24-000050
SEC(opens sec.gov)
Aug 294
Fenimore Christopher R.0001883850-24-000045
SEC(opens sec.gov)

Companies

REGENERON PHARMACEUTICALS, INC.EVP Finance CFOREGN

Address

777 OLD SAW MILL RIVER ROAD

TARRYTOWN, NY, 10591